【摘 要】
:
BACKGROUND Cetuximab in combination with oral fluoropyrimidine(FP)remains controversial in metastatic colorectal cancer(mCRC).In view of the regional variation
【机 构】
:
DepartmentofClinicalOncology,DepartmentofClinicalOncology,ClinicalOncologyCentre,DepartmentofPharmac